Cas:81581-27-3 Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate manufacturer & supplier

We serve Chemical Name:Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate CAS:81581-27-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate

Chemical Name:Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate
CAS.NO:81581-27-3
Synonyms:ethyl 3-(1,3-benzodioxol-5-yl)-3-oxopropanoate;MFCD01463468
Molecular Formula:C12H12O5
Molecular Weight:236.22100
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:358.8ºC at 760 mmHg
Density:1.275g/cm3
Index of Refraction:1.54
PSA:61.83000
Exact Mass:236.06800
LogP:1.55120

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like ethyl 3-(1,3-benzodioxol-5-yl)-3-oxopropanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD01463468 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD01463468 Use and application,ethyl 3-(1,3-benzodioxol-5-yl)-3-oxopropanoate technical grade,usp/ep/jp grade.


Related News: Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate manufacturer The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate supplier The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate vendor But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate factory But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed.